Ansley Clinic in Ansley, NE - Family Medicine

Ansley Clinic is a primary clinic (Family Medicine) in Ansley, Nebraska. The current practice location for Ansley Clinic is 706 Main St., Ansley, Nebraska. For appointments, you can reach them via phone at (308) 935-1367. The mailing address for Ansley Clinic is Po Box 690, 145 Memorial Drive, Broken Bow, Nebraska and phone number is (308) 872-2486.

Ansley Clinic is licensed to practice in Nebraska (license number ) and its NPI number is 1841312584. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (308) 935-1367.

Contact Information

	Ansley Clinic
	706 Main St. Ansley NE 68814-0706
	(308) 935-1367
	(308) 872-2027

Primary Care Clinic Profile

Full Name	Ansley Clinic
Speciality	Family Medicine
Location	706 Main St., Ansley, Nebraska
Authorized Official Name and Position	David A Minnick (OWNER PARTNER)
Authorized Official Contact	3088722486
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ansley Clinic Po Box 690 145 Memorial Drive Broken Bow NE 68822-0690 Ph: (308) 872-2486	Ansley Clinic 706 Main St. Ansley NE 68814-0706 Ph: (308) 935-1367

NPI Details:

NPI Number	1841312584
Provider Enumeration Date	04/04/2007
Last Update Date	06/11/2008

Medical Identifiers

Medical identifiers for Ansley Clinic such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1841312584	NPI	-	NPPES
28D0942874	Other	NE	CLIA NUMBER

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	(Nebraska)	Primary

News Archive

IASLC commends pembrolizumab drug approval for cutting-edge lung cancer treatment

The International Association for the Study of Lung Cancer (IASLC) says the move by the U.S. Food and Drug Administration (FDA) to grant accelerated approval for a cutting-edge lung cancer treatment is a positive step forward that may help many patients improve their survival.

Hapten Sciences plans to initiate Phase 1 clinical trial for new poison ivy vaccine

Hapten Sciences, Inc., a privately held biotechnology company, announced today that it has filed an Investigational New Drug (IND) application and is now planning to initiate dosing of healthy volunteers in a first-in-human Phase 1 clinical trial of its lead product candidate, PDC-APB, a novel, first-in-class, compound in development for a new indication to prevent contact dermatitis due to exposure to poison ivy, oak, and sumac.

President's fiscal year 2011 budget: FDA requests $4.03 billion for promoting and protecting public health

The U.S. Food and Drug Administration is requesting $4.03 billion to promote and protect public health as part of the President's fiscal year 2011 budget - a 23 percent increase over the agency's current $3.28 billion budget.

GOP plan to reclaim White House will turn Obama's words against him

The Washington Post reports on the Republican battle plan, which will undoubtedly include Obama's past claims about lowering the cost of insurance premiums. The Associated Press reports on how the GOP primary race has yet to "fully test" candidate Mitt Romney's health care record. Also, The Hill reports that the Republican presidential field appears to be "moving to the right" on abortion issues.

Ansley Clinic - Primary Care in Ansley, NE